Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elio Mazzone

Showing results (151-160 of 188) with videos related to

Pageof 19
Sort By:
European Urology Focus|December 24, 2025
Does the Accuracy of Prostate-specific Antigen Density in Identifying Clinically Significant Prostate Cancer Change with Prostate Volume?Leonardo Quarta, Francesco Pellegrino, Armando Stabile, et al.
European Urology|March 3, 2021
The Impact of Previous Prostate Surgery on Surgical Outcomes for Patients Treated with Robot-assisted Radical Cystectomy for Bladder CancerGiuseppe Rosiello, Pietro Piazza, Victor Tames, et al.
Minerva Urology and Nephrology|October 26, 2022
A nomogram to predict pathologic T2 stage in candidates to robot-assisted radical prostatectomy with iT3 prostate cancer on preoperative multiparametric MRI: results from a multi-institutional collaborationCarlo A Bravi, Elio Mazzone, Paolo Dell'oglio, et al.
Prostate Cancer and Prostatic Diseases|January 20, 2023
Correction to: Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictionsAlberto Martini, Alae Touzani, Elio Mazzone, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 11, 2024
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [<sup>99m</sup>Tc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II studyLeonardo Quarta, Elio Mazzone, Donato Cannoletta, et al.
European Urology Oncology|May 18, 2026
The Diagnostic Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Patients with Rising PSA After Radical Prostatectomy and Postoperative Radiotherapy: A Systematic Review and Meta-analysisDonato Cannoletta, Elio Mazzone, Francesco Di Bello, et al.
European Urology|July 25, 2022
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 StudyGiorgio Gandaglia, Elio Mazzone, Armando Stabile, et al.
Prostate Cancer and Prostatic Diseases|June 2, 2025
Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional seriesLeonardo Quarta, Armando Stabile, Francesco Pellegrino, et al.
BJU International|March 17, 2020
Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node-positive penile squamous cell carcinomaMarco Bandini, Maarten Albersen, Juan Chipollini, et al.
BJU International|June 2, 2026
Proficiency-based training and evidence-based methodology: a systematic review and meta-analysisRuben De Groote, Edoardo Beatrici, Maria Peraire Lores, et al.
Pageof 19

Showing results (151-160 of 188) with videos related to

Sort By:
Pageof 19
European Urology Focus|December 24, 2025
Does the Accuracy of Prostate-specific Antigen Density in Identifying Clinically Significant Prostate Cancer Change with Prostate Volume?Leonardo Quarta, Francesco Pellegrino, Armando Stabile, et al.
European Urology|March 3, 2021
The Impact of Previous Prostate Surgery on Surgical Outcomes for Patients Treated with Robot-assisted Radical Cystectomy for Bladder CancerGiuseppe Rosiello, Pietro Piazza, Victor Tames, et al.
Minerva Urology and Nephrology|October 26, 2022
A nomogram to predict pathologic T2 stage in candidates to robot-assisted radical prostatectomy with iT3 prostate cancer on preoperative multiparametric MRI: results from a multi-institutional collaborationCarlo A Bravi, Elio Mazzone, Paolo Dell'oglio, et al.
Prostate Cancer and Prostatic Diseases|January 20, 2023
Correction to: Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictionsAlberto Martini, Alae Touzani, Elio Mazzone, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 11, 2024
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [<sup>99m</sup>Tc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II studyLeonardo Quarta, Elio Mazzone, Donato Cannoletta, et al.
European Urology Oncology|May 18, 2026
The Diagnostic Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Patients with Rising PSA After Radical Prostatectomy and Postoperative Radiotherapy: A Systematic Review and Meta-analysisDonato Cannoletta, Elio Mazzone, Francesco Di Bello, et al.
European Urology|July 25, 2022
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 StudyGiorgio Gandaglia, Elio Mazzone, Armando Stabile, et al.
Prostate Cancer and Prostatic Diseases|June 2, 2025
Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional seriesLeonardo Quarta, Armando Stabile, Francesco Pellegrino, et al.
BJU International|March 17, 2020
Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node-positive penile squamous cell carcinomaMarco Bandini, Maarten Albersen, Juan Chipollini, et al.
BJU International|June 2, 2026
Proficiency-based training and evidence-based methodology: a systematic review and meta-analysisRuben De Groote, Edoardo Beatrici, Maria Peraire Lores, et al.
Pageof 19